So I got the heads up about this baby from writer/director, Jim Ojala. Jim has a professional background in Special Makeup/Creature FX (Buffy the Vampire Slayer, Deadgirl, PROXY, Hellboy 2, Where the Wild Things Are, Pacific Rim, etc.)- HE WORKED ON BUFFY!!!! *SQUEAL OF EXCITEMENT* Ahem…I’m back….So how does his special makeup background fit in? Well, Strange Nature is an eco-thriller that revolves around the ongoing unsolved frog deformity outbreaks in the U.S. and the dangerous places they may lead. With Jim’s awesome special effects background, he and the rest of his team can bring the more fantastic elements of where these deadly deformities can lead to startling realism in the film….plus it helps keep practical FX alive! If people believe it on screen maybe they’ll pay attention to the real problem as well.
Also cool is the support they’ve gotten from the ecological community. One of their strongest supporters, Dr. Pieter Johnson of University of Colorado, and his research team found a population of frogs in Oregon this year where every frog suffered a deformity…100% deformity rate. The problem is growing and the cast and crew of Strange Nature hope to expose that.
Right now, these guys are working with Kickstarter to try to raise funds for the film. They only have 6 days left to raise the money (so far they’re halfway there!) so if this is the sort of thing you’d like to see, click the link above, swing by and check out their Kickstarter and donate a buck or two!
You can also check out their website to learn more about the film including what they’ve done so far to get started as well as lots of videos! Just click that link there that says “website” and away you’ll go!
I dunno, I think it looks pretty cool and pretty unique so I’d definitely like to see this thing get made.
Posted on 2013.4.October, in American Cinema, American Indie, Creature Feature, Lo-Budget, News and tagged ecological thrillers, frog deformity outbreaks, jim ojala, strange nature, things I'd like to see made. Bookmark the permalink. 6 Comments.